aap Implantate Completes Sale of Biomaterials Unit

aap Implantate completed the sale of its aapBiomaterials subsidiary. The buyer is Keensight Capital, and aap received proceeds of ~€36.6MM (~€35MM/~US $40MM after transaction costs).

aap is now a pure player in trauma with three platform technologies: LOQTEQ®, silver coating and magnesium.

Sources: aap Implantate AG;...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us